Acquire
Target screening, commercial diligence and growth logic for companies seeking acquisition-led expansion.
A sector-specific advisory platform for crop protection, biologicals and plant nutrition companies making high-consequence decisions in complex markets.
Talk to DextraDextra helps crop input companies assess targets, prepare divestments, structure partnerships and validate assets before capital is committed.

Crop input transactions depend on registrations, data-package quality, channel access, customer relationships, product fit and the buyer’s ability to scale. Dextra’s role is to separate strategic value from surface-level appeal.
Target screening, commercial diligence and growth logic for companies seeking acquisition-led expansion.
Preparation and positioning of intellectual property, registrations, product rights or non-core portfolios for strategic buyers.
Partner search, licensing, distribution agreements, co-development options and broader strategic agreements.
Technology, formulation, active ingredient, registrations, data package, product rights and protectability.
Crop fit, customer demand, competitive pressure, price resilience and realistic growth potential.
Distributor relationships, customer concentration, technical influence and route-to-market durability.
Acquisition, divestment, licensing, partnership or staged investment routes, depending on the asset.
The work is designed to support real decisions: whether to approach a target, how to position an asset, what risks should affect value and how the deal can translate into growth.
Clarify the strategic gap, value-creation logic, target profile and transaction route.
Identify companies, product rights, IP, registrations, technologies and partners worth prioritising.
Test revenue assumptions, market fit, regulatory exposure, channel strength and customer quality.
Translate diligence into value drivers, risk flags, deal conditions and negotiation priorities.
Prioritise post-deal growth, market access, integration, portfolio actions and partner execution.
Mapping and prioritising targets, products, technologies and market-access platforms.
Preparing assets, IP or portfolios with a credible buyer logic and sharper value story.
Validating growth claims, customer quality, channel defensibility and regional risk.
Assessing product rights, registrations, dossiers, data packages and country dependencies.
Supporting licensing, distribution, partner search, joint ventures and alliance models.
Turning deal logic into an execution roadmap for markets, products and channels.
What is actually owned, protected, registered or transferable?
Separates strategic substance from cosmetic portfolio breadth.
Where is demand resilient, differentiated and commercially accessible?
Tests whether growth assumptions can survive market reality.
What registrations, renewals, data ownership or country risks affect value?
Connects deal value with timing and risk.
Will revenue remain stable after ownership or partner changes?
Tests whether customer and distributor relationships are transferable.

Share the asset, geography, product category or partner question. Dextra can help structure the thesis, define the diligence path, identify the risks that matter and translate the opportunity into practical next steps. The conversation can start early, before a target is public, a divestment is prepared or a strategic agreement is ready to negotiate.